Gibco™ DMEM, high glucose

Mammalian cell culture media HAOSMC

Experiment
Mammalian cell culture media HAOSMC
Product
Gibco™ DMEM, high glucose from Fisher Scientific
Manufacturer
Fisher Scientific

Protocol tips

Protocol tips
Media with 10% FBS, penicillin (100 U/mL) and streptomycin (100 U/mL)

Publication protocol

Human aortic smooth muscle cells (HASMCs) were obtained from Invitrogen and grown at 37 °C in humidified air containing 5% CO2. They were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS, penicillin (100 U/mL) and streptomycin (100 U/mL). This medium was replaced with fresh medium every 2 days.

Full paper   Login or join for free to view the full paper.

Reviews

Gibco™ DMEM, high glucose from Fisher Scientific has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Mammalian cell culture media HAOSMC using Gibco™ DMEM, high glucose from Fisher Scientific.

Paper title
Advanced glycation end products promote human aortic smooth muscle cell calcification via activating NF-κB and down-regulating IGF1R expression
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Fisher Scientific for Gibco™ DMEM, high glucose below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Mammalian cell culture media HAOSMC using Gibco™ DMEM, high glucose from Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms